Release Date: 30/11/09 10:11 Summary: Placement and Share Purchase Plan Price Sensitive: Yes Download Document 55.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%